IRVINE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it has engaged Maxim Group LLC, to act as the Company’s exclusive financial advisor to identify potential strategic merger and acquisition partnership alternatives.

加利福尼亚州欧文，2023年12月20日（环球通讯社）--重塑生命科学公司（Nasdaq:RSLS），这家由医生主导的减肥和代谢健康解决方案公司，今天宣布，它已经聘请Maxim Group LLC担任公司的独家财务顾问，以确定潜在的战略并购合作伙伴替代方案。

The Company does not have a defined timeline for such a transaction and cannot provide any assurance whether or when any transaction will be announced or consummated. About Maxim Group LLCFounded in 2002, Maxim Group is a leading full-service investment bank, securities and wealth management firm headquartered in mid-town Manhattan providing a comprehensive array of financial services including investment banking, global institutional sales, equity research, fixed income and derivative sales & trading, merchant capital, private wealth management, and prime brokerage services to a diverse range of corporate clients, institutional investors and high-net-worth individuals.

公司对此类交易没有明确的时间表，也无法保证是否或何时宣布或完成任何交易。关于Maxim Group LLC成立于2002年，Maxim Group是一家领先的全方位服务投资银行、证券和财富管理公司，总部位于曼哈顿中城，提供全面的金融服务，包括投资银行、全球机构销售、股权研究、固定收益和衍生产品销售与交易、商业资本、私人财富管理、，为各类企业客户、机构投资者和高净值个人提供大宗经纪服务。

Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board (MSRB). To learn more about Maxim Group, visit www.maximgrp.com. About ReShape Lifesciences® ReShape Lifesciences® is America’s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease.

Maxim Group是美国证券交易委员会和市政证券规则制定委员会（MSRB）的注册经纪交易商。要了解有关Maxim Group的更多信息，请访问www.maximgrp.com。关于重塑生命科学®重塑生命科学®是美国首屈一指的减肥和代谢健康解决方案公司，提供管理和治疗肥胖和代谢疾病的经验证的产品和服务的综合组合。

The FDA-approved Lap-Band® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system utilizes a proprietary vagus nerve bl.

FDA批准的Lap-Band®系统提供了对肥胖的微创长期治疗，是胃旁路术或袖状胃切除术等更具侵入性的外科吻合器手术的替代方法。研究性糖尿病集团刺激神经调节™（DBSN™)该系统利用专有的迷走神经bl。